Top Markets
#1 GoPlus Security GoPlus Security +36.55%
#2 GAIB AID GAIB AID +24.67%
#3 Tutorial Tutorial +21.29%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.22%
#5 SkyAI SkyAI +16.67%
#6 Pons Pons +14.26%
#7 Verus Coin Verus Coin +13.11%
#8 Status Status +12.83%
#9 Ontology Gas Ontology Gas +10.37%
#10 Talus Network Talus Network +10.37%
Coin of the day
GoPlus Security GoPlus Security
設定
言語
日本
通貨
USD
テーマ
Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS
株式のランク #33745
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
株価
$0.11637199
時価総額
$7.20M
変化（1日）
3.13%
変化（1年）
171.06%
国
AU
取引 Vectus Biosystems Limited (VBS)

カテゴリー

Healthcare
Vectus Biosystems Limited（VBS）の配当利回りの履歴
Vectus Biosystems Limited（銘柄コード: VBS）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Vectus Biosystems Limited（VBS）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE